Stay updated on Phase 2 AMEERA-4 Clinical Trial
Sign up to get notified when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.
Latest updates to the Phase 2 AMEERA-4 Clinical Trial page
- Check3 days agoChange DetectedA general government funding/operational notice at the bottom of the page was removed. The core trial information—title, objective, design, eligibility criteria, endpoints, and locations—remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record shows an updated Last Update Posted date (2025-09-18) and related QC entries. No changes were made to the trial design, eligibility criteria, or outcome measures.SummaryDifference0.4%
- Check46 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check53 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check60 days agoChange DetectedAdds recent dates and a new Sanofi ACT16106 plain-language results link; removes older 2022 dates and a generic last update line, signaling a move toward current information and additional guidance.SummaryDifference1%
- Check67 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a maintenance update to core content. The 'Back to Top' link was removed, a minor UI change with low significance.SummaryDifference0.2%
Stay in the know with updates to Phase 2 AMEERA-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.